Mpride V1 Tablet SR
Marketer
Ajanta Pharma Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Mpride V1 Tablet SR
Diabetace V1 Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Administer Diabetace V1 ER Tablets with food, consistently at the same time daily for optimal efficacy. Dosage will be determined by your physician and may be adjusted based on your blood glucose response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, potentially causing kidney damage, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan encompassing dietary adjustments, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect. Learn to recognize its symptoms—sweating, dizziness, headache, tremors—and implement appropriate countermeasures. Maintain regular mealtimes and carry a readily available fast-acting glucose source, like sugary snacks or fruit juice. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes mellitus, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of heart disease to your physician before commencing treatment, as it may be unsuitable. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.
Uses of Mpride V1 Tablet SR
Managing type 2 diabetes
Major Benefits of Mpride V1 Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Mpride V1 Tablet SR on an empty stomach.
Common Side effects of Mpride V1 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Mpride V1 Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Mpride V1 Tablet SR on an empty stomach.
How Mpride V1 Tablet SR works:
Mpride V1 Extended-Release Tablets contain a triple-action formulation to manage diabetes.
SAFETY ADVICE
AlcoholUNSAFE
Combining Mpride V1 Tablet SR and alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Mpride V1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Mpride V1 Tablets may pose a risk to breastfeeding infants. Available evidence from human studies indicates potential transfer to breast milk, possibly causing harm to the nursing child.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Mpride V1 Tablet SR is potentially hazardous for individuals with kidney impairment and should be avoided. A physician's consultation is advised. Furthermore, this medication is unsuitable for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Individuals with liver impairment should use Mpride V1 Tablet SR cautiously, potentially requiring dosage modifications. Consult a physician for guidance. For those with mild to moderate liver disease, initiation should be at a low dosage; however, its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Mpride V1 Tablet SR :
Should you forget to take a dose of Mpride V1 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mpride V1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |


